Envista Holdings Corporation participated in the 2026 Global Healthcare Conference, featuring a Q&A session with CEO Paul Keel and CFO Eric Hammes. The discussion included insights into the company's dental consumables and equipment business. No prepared remarks were given, focusing instead on direct interaction with analysts and attendees. This engagement highlights Envista's ongoing communication with investors and industry stakeholders.
Envista Holdings Corporation's presentation at the 2026 Global Healthcare Conference provides context for healthcare sector activity. For readers following healthcare stocks, here is Pluang's market snapshot as of Sep 16, 2026 00:52 WIB: out of 91 priced US health-sector stocks, 28 rose and 63 fell. Notable movers include Illumina, Inc. (ILMN) with a price of USD 225.13 and a 1-day change of +8.13%, 10X Genomics Inc (TXG) at USD 75.05 with +7.05%, and BridgeBio Pharma Inc (BBIO) at USD 67.64 with -6.56%.
Waystar Holding Corp, a healthcare software company valued at around $5.1 billion, saw its stock rise 8.6% to $27.05 following reports that it is evaluating strategic options, including a potential sale. Barclays set a new price target of $30, sugges...
MasterCraft Boat Holdings reported fiscal Q4 2026 adjusted earnings of $0.67 per share and revenue of $129.94 million, surpassing estimates. Revenue growth was driven by its Performance and Wake business and the Marine Products acquisition, which add...
Redwood Trust's CFO, Carillo Brooke, increased her stake by purchasing 26,065 shares, showing confidence despite a major shareholder urging the board to consider selling the company. The stock trades at a 33% discount to its GAAP book value due to ri...
BioMarin Pharmaceutical received a price target upgrade to $97 from BMO Capital, reflecting about 50% upside from current levels. This follows positive Phase 3 trial results for VOXZOGO®, a treatment for hypochondroplasia, showing significant growth ...
Comcast announced a strategic restructuring to separate its connectivity and technology division from its media operations, including NBCUniversal and Sky. UBS raised Comcast's price target to $27, suggesting a 10% upside from current prices. The com...
